宜明昂科-B(01541)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01541 宜明昂科-B

未开盘 01-30 16:08:04

4.530

-0.140

-3.00%

最高4.700	最低4.500	成交量87.44万
今开4.670	昨收4.670	日振幅4.28%
总市值19.57亿	流通市值19.05亿	总股本4.32亿
成交额403.08万	换手率0.21%	流通股本4.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01541","market":"HK","secType":"STK","nameCN":"宜明昂科-B","latestPrice":4.53,"timestamp":1769760484002,"preClose":4.67,"halted":0,"volume":874400,"delay":0,"changeRate":-0.029978586723768668,"floatShares":420477305,"shares":432000000,"eps":-0.79,"marketStatus":"未开盘","change":-0.14,"latestTime":"01-30 16:08:04","open":4.67,"high":4.7,"low":4.5,"amount":4030834,"amplitude":0.042827,"askPrice":4.55,"askSize":600,"bidPrice":4.53,"bidSize":18600,"shortable":3,"etf":0,"ttmEps":-0.769,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769995800000},"marketStatusCode":0,"adr":0,"listingDate":1693843200000,"exchange":"SEHK","adjPreClose":4.67,"openAndCloseTimeList":[[1769736600000,1769745600000],[1769749200000,1769760000000]],"volumeRatio":0.5721857023163208,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01541","defaultTab":"news","newsList":[{"id":"2607033498","title":"每日卖空追踪 | 宜明昂科-B 01月29日卖空量成交5000股，卖空比例为0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607033498","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607033498?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675423,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间01月29日，跌3.11%，卖空量成交5000股，较上一交易日减少47.92%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129163743a6bae073&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129163743a6bae073&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2607303345","title":"宜明昂科-B01月29日主力净流出72.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607303345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607303345?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:15","pubTimestamp":1769674554,"startTime":"0","endTime":"0","summary":"01月29日, 宜明昂科-B股价跌3.11%，报收4.67元，成交金额574.2万元，换手率0.29%，振幅4.15%，量比0.69。宜明昂科-B今日主力资金净流出72.8万元，上一交易日主力净流入41.0万元。该股近5个交易日下跌4.69%，主力资金累计净流入25.1万元；近20日主力资金累计净流出555.9万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162322a6bad070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162322a6bad070&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2606796891","title":"宜明昂科-B01月28日获主力加仓41.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606796891","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606796891?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:15","pubTimestamp":1769588109,"startTime":"0","endTime":"0","summary":"01月28日, 宜明昂科-B股价涨0.84%，报收4.82元，成交金额610.1万元，换手率0.30%，振幅7.32%，量比0.48。宜明昂科-B今日主力资金净流入41.0万元，上一交易日主力净流入111.2万元。该股近5个交易日上涨0.21%，主力资金累计净流入25.2万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出477.7万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128161636a6b665ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128161636a6b665ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2606849796","title":"宜明昂科子公司---宜明凯尔IMC-015双抗专利正式递交差异化\"减脂增肌\"策略有望破局GLP-1肌肉流失痛点","url":"https://stock-news.laohu8.com/highlight/detail?id=2606849796","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606849796?lang=zh_cn&edition=full","pubTime":"2026-01-28 14:11","pubTimestamp":1769580660,"startTime":"0","endTime":"0","summary":"2026年1月28日，宜明昂科宣布子公司宜明凯尔自主研发的IMC-015双抗专利申请已递交，项目进入CMC和非临床研究阶段。肥胖是全球性健康问题，我国肥胖症患者众多，且肥胖会引发多种慢性病。GLP-1类药物虽减重效果显著，但会导致肌肉流失，维持肌肉质量是减肥重要挑战。IMC-015是宜明凯尔自主研发的双特异性抗体，能精准靶向调控肌肉生长抑制素信号通路，实现“减脂增肌”双重效应，体外研究显示其分子活性更优，与Bimagrumab相比，肌肉组织特异性提升，预期安全性更优。在肥胖小鼠模型中，IMC-015与司美格鲁肽联用增肌减脂药效明显优于同类药物，验证了其在GLP-1联合治疗中的潜力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128142827a6b609e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128142827a6b609e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2606423012","title":"每日卖空追踪 | 宜明昂科-B 01月26日卖空量成交5600股，卖空比例为0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606423012","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606423012?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416223,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间01月26日，跌2.93%，卖空量成交5600股，较上一交易日减少85.79%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163856a6ad756c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163856a6ad756c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2606788294","title":"宜明昂科-B盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606788294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606788294?lang=zh_cn&edition=full","pubTime":"2026-01-26 09:53","pubTimestamp":1769392408,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘09时53分，宜明昂科-B股票出现波动，股价急速下挫5.02%。截至发稿，该股报4.540港元/股，成交量19.34万股，换手率0.05%，振幅7.11%。宜明昂科-B股票所在的生物技术行业中，整体跌幅为1.96%。其相关个股中，中生北控生物科技、维亚生物、康希诺生物涨幅较大，振幅较大的相关个股有中生北控生物科技、维亚生物、来凯医药-B，振幅分别为17.28%、15.35%、14.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126095328a6ac0288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126095328a6ac0288&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2605744404","title":"每日卖空追踪 | 宜明昂科-B 01月23日卖空量成交1.4万股，卖空比例为0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605744404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605744404?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:30","pubTimestamp":1769157022,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间01月23日，跌2.45%，卖空量成交1.4万股，较上一交易日减少69.3%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163728a6a44a29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123163728a6a44a29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2605474422","title":"宜明昂科-B01月23日遭主力抛售17.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605474422","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605474422?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:15","pubTimestamp":1769156118,"startTime":"0","endTime":"0","summary":"01月23日, 宜明昂科-B股价跌2.45%，报收4.78元，成交金额768.7万元，换手率0.38%，振幅7.14%，量比0.59。宜明昂科-B今日主力资金净流出17.3万元，连续3日净流出，上一交易日主力净流出72.7万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为57.14%，平均跌幅为3.69%。该股近5个交易日下跌23.11%，主力资金累计净流出432.4万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出456.4万元，其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123161640a6a4309c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260123161640a6a4309c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2605743457","title":"港股异动 | 宜明昂科-B(01541)涨超5% 核心产品IMM01预期年底递交preBLA申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2605743457","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605743457?lang=zh_cn&edition=full","pubTime":"2026-01-22 14:51","pubTimestamp":1769064666,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，宜明昂科-B涨超5%，截至发稿，涨5.11%，报4.94港元，成交额834.81万港元。消息面上，1月21日晚，宜明昂科发布公告称，公司于2025年12月31日成功完成IMM01用于慢性粒-单核细胞白血病一线治疗的III期临床试验的104例患者招募，预期将于2026年3月底前完成中期分析所需的132 例患者招募。此外，公司计划于2026年底递交preBLA申请，其在动脉粥样硬化领域的Ib/II期研究也将推进至概念验证阶段。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 宜明昂科-B(01541)涨超5% 核心产品IMM01预期年底递交preBLA申请","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1610","BK1161","01541"],"gpt_icon":1},{"id":"2605105010","title":"宜明昂科-B(01541)：业务营运及临床开发维持正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2605105010","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605105010?lang=zh_cn&edition=full","pubTime":"2026-01-21 19:07","pubTimestamp":1768993647,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B 发布公告，本公司于2025年12月31日成功完成IMM01用于慢性粒-单核细胞白血病一线治疗的III期临床试验的104例患者招募，并预期将于2026年3月底前完成中期分析所需的132 例患者招募。截至本公告日期，董事会确认本集团的业务营运及临床开发维持正常，且本集团的业务营运及财务状况并无重大不利变动。凭藉差异化的分子设计，IMM01 表现出良好的安全性并证实其激活巨噬细胞的能力。本集团拥有IMM01的全球知识产权及商业化权利。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01541","BK1161"],"gpt_icon":1},{"id":"2604136360","title":"每日卖空追踪 | 宜明昂科-B 01月19日卖空量成交1600股，卖空比例为0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604136360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604136360?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:30","pubTimestamp":1768811422,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间01月19日，跌5.62%，卖空量成交1600股，较上一交易日减少60%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119163911a72ba9b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119163911a72ba9b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2604364136","title":"宜明昂科-B01月19日遭主力抛售158.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604364136","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604364136?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:15","pubTimestamp":1768810508,"startTime":"0","endTime":"0","summary":"01月19日, 宜明昂科-B股价跌5.62%，报收5.88元，成交金额1004.6万元，换手率0.40%，振幅6.90%，量比0.99。宜明昂科-B今日主力资金净流出158.3万元，连续4日净流出，上一交易日主力净流出76.0万元。近一年数据显示，该股主力连续4日净流出后，次日下跌概率为57.14%，平均跌幅为3.73%。该股近5个交易日下跌4.23%，主力资金累计净流出374.4万元；近20日主力资金累计净流出153.9万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119161550a43c07b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119161550a43c07b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2604136367","title":"宜明昂科-B盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604136367","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604136367?lang=zh_cn&edition=full","pubTime":"2026-01-19 13:25","pubTimestamp":1768800321,"startTime":"0","endTime":"0","summary":"2026年01月19日下午盘13时25分，宜明昂科-B股票出现波动，股价急速跳水5.14%。截至发稿，该股报5.910港元/股，成交量84.06万股，换手率0.20%，振幅4.98%。宜明昂科-B股票所在的生物技术行业中，整体跌幅为3.87%。其相关个股中，华昊中天医药-B、锦欣生殖、中生北控生物科技涨幅较大，振幅较大的相关个股有中慧生物-B、基石药业-B、锦欣生殖，振幅分别为11.99%、10.80%、9.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011913252597a2571d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011913252597a2571d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2604189821","title":"生物制品行业深度报告：MNC不断加码IO双抗，2026年重磅催化有望持续","url":"https://stock-news.laohu8.com/highlight/detail?id=2604189821","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604189821?lang=zh_cn&edition=full","pubTime":"2026-01-19 12:07","pubTimestamp":1768795650,"startTime":"0","endTime":"0","summary":"MNC不断加码IO双抗，2026年重磅催化有望持续目前全球共18款PD-1/VEGF双抗进入临床阶段，其中5款国产已BD出海。依沃西单抗：国内注册临床HARMONi-2和HARMONi-6试验OS数据有望于2026年成熟。海外临床目前围绕NSCLC进行全面布局，2025H2新开一项针对一线结直肠癌患者的美国注册临床。RC148：荣昌生物于近期与艾伯维达成6.5亿美元首付款及最高达49.5亿美元里程碑付款的独家授权许可协议。辉瑞已于2025年底开展SSGJ-707联合ITGB6ADC的I/II期临床，2026年有望开展更多联合ADC的探索性临床。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119123139a43b4e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119123139a43b4e4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09995","HK0000252160.HKD","LU2543165471.USD","09606","HK0000500386.USD","01541","01877","HK0000252152.HKD"],"gpt_icon":0},{"id":"2603931502","title":"每日卖空追踪 | 宜明昂科-B 01月15日卖空量成交1.16万股，卖空比例为1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603931502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603931502?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:30","pubTimestamp":1768465822,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间01月15日，跌2.4%，卖空量成交1.16万股，较上一交易日减少83.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164018a71dc735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164018a71dc735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","BK1161"],"gpt_icon":0},{"id":"2603528931","title":"宜明昂科-B01月15日遭主力抛售7.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603528931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603528931?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:16","pubTimestamp":1768464969,"startTime":"0","endTime":"0","summary":"01月15日, 宜明昂科-B股价跌2.40%，报收6.51元，成交金额634.0万元，换手率0.23%，振幅6.60%，量比0.51。宜明昂科-B今日主力资金净流出7.7万元，上一交易日主力净流出169.3万元。该股近5个交易日上涨1.72%，主力资金累计净流出55.6万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出4.9万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115162617a4c6c34a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115162617a4c6c34a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2603285936","title":"宜明昂科-B01月14日主力净流出169.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2603285936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603285936?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:15","pubTimestamp":1768378545,"startTime":"0","endTime":"0","summary":"01月14日, 宜明昂科-B股价跌0.89%，报收6.67元，成交金额1305.7万元，换手率0.45%，振幅7.43%，量比0.85。宜明昂科-B今日主力资金净流出169.3万元，上一交易日主力净流入36.9万元。该股近5个交易日下跌0.89%，主力资金累计净流出8.9万元；近20日主力资金累计净流出3.5万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162112a4c258cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114162112a4c258cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0},{"id":"2603646356","title":"张江药谷企业加速从实验室到全球市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2603646356","media":"张江发布","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603646356?lang=zh_cn&edition=full","pubTime":"2026-01-14 13:05","pubTimestamp":1768367141,"startTime":"0","endTime":"0","summary":"近期，多家张江药谷企业在新药申报、适应症拓展及技术平台突破等方面取得重要进展。张江药谷通过制度创新、服务创新、生态创新，持续推动创新成果高效转化，加速产品上市与迭代。此次获批标志着阿美乐实现了从早期到晚期EGFR突变NSCLC患者全病程的治疗覆盖。宜明昂科阿沐瑞芙普α单药治疗原发性膜性肾炎的IND获受理1月7日，张江药谷企业宜明昂科宣布，公司自主研发的阿沐瑞芙普α单药治疗原发性膜性肾炎的临床试验申请正式获得NMPA受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114131239953cb11d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114131239953cb11d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01541","00013","BK1583","BK1587","BK1191","03692","BK1589","BK1588"],"gpt_icon":0},{"id":"1130056406","title":"港股生物医药股集体走高！百奥赛图-B涨超11%，来凯医药-B涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130056406","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130056406?lang=zh_cn&edition=full","pubTime":"2026-01-14 09:43","pubTimestamp":1768354999,"startTime":"0","endTime":"0","summary":"1月14日，港股生物医药股集体走高，$百奥赛图-B(02315)$涨超11%，$来凯医药-B(02105)$、$宜明$昂科(02216)$-B(01541)$涨超5%，$微创$机器人(300024)$-B(02252)$涨超4%，$启明医疗-B(02500)$、$华领医药-B(02552)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c007f4db8ce2cc0ef142359e6d915978","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","01541","BK1617","02552","BK1191","02315","BK1583","02252","BK1100","02216","02105","02500"],"gpt_icon":0},{"id":"2603689398","title":"每日卖空追踪 | 宜明昂科-B 01月13日卖空量成交6万股，卖空比例为2.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689398","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603689398?lang=zh_cn&edition=full","pubTime":"2026-01-13 16:30","pubTimestamp":1768293022,"startTime":"0","endTime":"0","summary":"宜明昂科-B北京时间01月13日，涨9.61%，卖空量成交6万股，较上一交易日增加9.49%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113164231a714fb36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260113164231a714fb36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01541"],"gpt_icon":0}],"profile":{"websiteUrl":"http://immuneonco.com","stockEarnings":[{"period":"1week","weight":-0.0523},{"period":"1month","weight":-0.223},{"period":"3month","weight":-0.506},{"period":"6month","weight":-0.5576},{"period":"1year","weight":-0.1221},{"period":"ytd","weight":-0.223}],"compareEarnings":[{"period":"1week","weight":0.0238},{"period":"1month","weight":0.0685},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.1175},{"period":"1year","weight":0.3541},{"period":"ytd","weight":0.0685}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"宜明昂科生物医药技术（上海）股份有限公司是一家主要从事开发肿瘤免疫疗法的中国公司。该公司的主要业务包括开发用于系统利用先天性和适应性免疫的生物技术，以及开发下一代肿瘤免疫疗法，免疫疗法主要专注于适应性免疫系统。该公司的核心产品IMM01是创新靶向CD47的分子。该公司主要在中国国内和海外市场开展业务。","exchange":"SEHK","name":"宜明昂科-B","nameEN":"IMMUNEONCO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宜明昂科-B(01541)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宜明昂科-B(01541)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宜明昂科-B,01541,宜明昂科-B股票,宜明昂科-B股票老虎,宜明昂科-B股票老虎国际,宜明昂科-B行情,宜明昂科-B股票行情,宜明昂科-B股价,宜明昂科-B股市,宜明昂科-B股票价格,宜明昂科-B股票交易,宜明昂科-B股票购买,宜明昂科-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宜明昂科-B(01541)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宜明昂科-B(01541)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}